Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Continuous Positive Airway Pressure (CPAP) in COVID-19 Confirmed or Suspected Patients

NCT04390191 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT04390191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04390191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Continuous Positive Airway Pressure (CPAP) in COVID-19 Confirmed or Suspected Patients
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Terminated
Start date
May 7, 2020
Completion date
July 7, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid, covid-19